Novotech Releases 2025 Report Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

The potential for accidental transmission of disease has also served as the main rationale for the development and approval of several recombinant blood factors, as well as hepatitis B vaccines ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

Hepatitis A is a very contagious liver infection that is common in many parts of the world. Here's more about the vaccine for babies and kids.

The hepatitis B vaccine is also effective, but maintaining immunity often requires booster shots. Moreover, it doesn't help ...

Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.